Clinical Trial of GeoVax’s AIDS Vaccine Moves Forward
As President Obama prepares to release his U.S. AIDS strategy, at least one pharmaceutical company is readying a crucial clinical trial of its vaccine against HIV/AIDS.
geovax
Potential Breakthrough in Search for AIDS Vaccine
Scientists at the Scripps Research Institute have isolated two antibodies that can prevent patients with HIV from developing severe AIDS.
Special Report: Fighting the U.S. AIDS Epidemic
An estimated 1.2 million people in the U.S. have the HIV virus. OneMedPlace speaks with AIDS advocate Michael Manganiello about the scope of the epidemic, the possibility of a vaccine, and what needs to happen to make a national AIDS strategy a reality.